Not checked for notices yet.
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
Marisa Granato, Maria Saveria Gilardini Montani, Roberta Santarelli and 3 more
Journal of Experimental & Clinical Cancer Research · 2017
Cited by papers we hold 3
- Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers · 2025No notice
- Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways · 2021No notice
- Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects · 2018No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.